human | Q5 |
P734 | family name | Ulmer | Q15730695 |
Ulmer | Q15730695 | ||
Ulmer | Q15730695 | ||
P106 | occupation | researcher | Q1650915 |
Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q35870483 | A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients |
Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Search more.